Novogen Limited

Press Releases

2015-August-31	Novogen Announces the Outcome of a Comprehensive Science Review (in PDF)
2015-August-5	Novogen Strengthens Position in ATM Platform by Lodging New Patents (in PDF)
2015-July-30	Newly Appointed Acting CEO Outlines Immediate Plans for Novogen, Company Confirms its Commitment to Bringing Technology Platforms to the Clinic (in PDF)
2015-July-22	Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board (in PDF)
2015-July-22	Resignation of CEO (in PDF)
2015-July-16	Anisina Receives Orphan Drug Designation from FDA for Neuroblastoma (in PDF)
2015-July-14	Pre-clinical Studies Suggest Anisina may Improve Chemotherapy Effectiveness in Childhood Cancer. (in PDF)
2015-July-1	Appointment of Interim Chairman (in PDF)
2015-June-24	Results of General Meeting (in PDF)
2015-June-24	General Meeting - Chairman's Address (in PDF)
2015-June-24	Anisina on Track to Enter Clinic in 2016 (in PDF)
2015-June-12	Novogen to Present at Bio International Convention Philadelphia 2015 (in PDF)
2015-June-5	Studies Confirm TRXE-009 Crosses the Blood Brain Barrier (in PDF)
2015-June-3	Novogen Expands Board with Two New Appointments (in PDF)
2015-June-2	Closing of Rights Issue Entitlement Offer, Notice of Shortfall (in PDF)
2015-May-28	ATM Technology Extended with New Patent Lodgement (in PDF)
2015-May-27	Novogen to Present at Brain Tumor Biotech Summit 2015 (in PDF)
2015-May-26	Novogen to Present at the 2015 Marcum Microcap Conference (in PDF)
2015-May-18	Novogen to Present at Hong Kong Investor Conference (in PDF)
2015-May-14	Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies (in PDF)
2015-May-8	Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells (in PDF)
2015-May-6	Rights Issue Documentation Dispatched to Shareholders (in PDF)
2015-April-29	Novogen Completes the Private Placement of Equity (in PDF)
2015-April-28	Novogen Regains Full Compliance with NASDAQ Listing Rule (in PDF)
2015-April-27	Novogen Posts Details on Rights Issue Offering for Shareholders (in PDF)
2015-April-22	Cantrixil Receives Orphan Drug Designation from FDA (in PDF)
2015-April-21	Novogen Conducts Private Placement and Announces Rights Offering to Shareholders (in PDF)
2015-April-21	Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer (in PDF)
2015-April-17	Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer (in PDF)
2015-April-9	Australian Studies Confirm Anisina as Potential Important New Weapon against Melanoma (in PDF)
2015-April-2	Novogen Engages Leading US Investor Relations Firm (in PDF)
2015-March-30	Yale University and Novogen Release Data on Cantrixil Mode of Action (in PDF)
2015-March-18	Potential of Anisina to Become Major New Chemotherapy Confirmed by CODA Study (in PDF)
2015-March-6	Cantrixil Data to be Presented at Two Major Conferences (in PDF)
2015-March-4	Novogen General Meeting Chairman's Address (in PDF)
2015-March-4	US Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells (in PDF)
2015-March-3	Novogen to Present at Ausbiotech "Broker Meets Biotech" Event (in PDF)
2015-February-23	Novogen Limited (ASX:NRT) - Erratum to Half Yearly Report and Accounts (in PDF)
2015-February-23	Novogen to Present at SACHS Cancer Bio Partnering & Investment Forum (in PDF)
2015-February-20	Interim Report for the Half-Year Ended December 31, 2014 (in PDF)
2015-February-19	Novogen Investor Briefing Well Received (in PDF)
2015-February-17	Novogen to Hold Investor Briefing in New York (in PDF)
2015-February-11	Novogen Lodges Key Super-Benzopyran Patent (in PDF)
2015-February-2	Novogen to Present at BIO & CEO Investor Conference 9th & 10th February, 2015 (in PDF)
2015-January-29	Nasdaq Accepts Novogen Plan to Comply with Nasdaq Listing Rules (in PDF)
2015-January-23	Novogen CEO to Present at Biotech and Money Investor Conference in London (in PDF)
2015-January-16	Early Termination of Funding Arrangement (in PDF)
2015-January-16	Novogen Announces Important Discovery in Regenerative Medicine Program (in PDF)
2015-January-7	Novogen to Conduct Shareholder/Investor Briefing in New York (in PDF)
2014	2014 Press Releases
2013	2013 Press Releases